Inappropriate prescribing: a systematic overview of published assessment tools
- 2.4k Downloads
Criteria to assess the appropriateness of prescriptions might serve as a helpful guideline during professional training and in daily practice, with the aim to improve a patient’s pharmacotherapy.
To create a comprehensive and structured overview of existing tools to assess inappropriate prescribing.
Systematic literature search in Pubmed (1991–2013). The following properties of the tools were extracted and mapped in a structured way: approach (explicit, implicit), development method (consensus technique, expert panel, literature based), focused patient group, health care setting, and covered aspects of inappropriate prescribing.
The literature search resulted in 46 tools to assess inappropriate prescribing.Twenty-eight (61%) of 46 tools were explicit, 8 (17%) were implicit and 10 (22%) used a mixed approach. Thirty-six (78%) tools named older people as target patients and 10 (22%) tools did not specify the target age group. Four (8.5%) tools were designed to detect inappropriate prescribing in hospitalised patients, 9 (19.5%) focused on patients in ambulatory care and 6 (13%) were developed for use in long-term care. Twenty-seven (59%) tools did not specify the health care setting. Consensus methods were applied in the development of 19 tools (41%), the others were based on either simple expert panels (13; 28%) or on a literature search (11; 24%). For three tools (7%) the development method was not described.
This overview reveals the characteristics of 46 assessment tools and can serve as a summary to assist readers in choosing a tool, either for research purposes or for daily practice use.
KeywordsDrug-related problems inappropriate prescribing assessment tool drug safety
Conflicts of interest
The authors declare that they have no conflicts of interest.
Contributions of authors statement (with relevance to the ICMJE Guidelines)
C. P. Kaufmann: Contribution to the study design and the analysis and interpretation of data, involvement in the literature search, manuscript writing, final approval of the version to be published.
R. Tremp: Contribution to the study design and the analysis and interpretation of data, conducted the literature search and the mapping of the different tools.
K.E. Hersberger: Manuscript review and final approval of the version to be published.
M.L. Lampert: Contribution to the study design and the analysis and interpretation of data, manuscript review and final approval of the version to be published
- 16.Haque R (2009) ARMOR: A Tool to Evaluate Polypharmacy in Elderly Persons. Annals of Long-Term Care 17(6):26–30Google Scholar
- 24.Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL (2003) Lipton RB (2004) Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc 44(2):142–151Google Scholar
- 37.National Committee for Quality Assurance (NCQA) (2008) HEDIS - High Risk Medications (DAE-A) and potentially harmful Drug-Disease Interactions (DDE) in the Elderly. www.ncqa.org/tabid/598/Default.aspx. assessed 10.02.2011
- 38.Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J (2009) The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 27(3):153–159PubMedCentralPubMedCrossRefGoogle Scholar
- 44.Holt S, Schmiedl S, Thürmann PA (2011) PRISCUS-Liste potenziell inadäquater Medikation für ältere Menschen. http://priscus.net/download/PRISCUS-Liste_PRISCUS-TP3_2011.pdf. Accessed 01.02.2011
- 48.American Medical Directors Association (AMDA) Top 10 Particularly Dangerous Drug Interactions in Long Term Care. AMDA. http://www.amda.com/tools/clinical/m3/topten.cfm. Accessed 07.04. 2011
- 50.Lechevallier-Michel N, Gautier-Bertrand M, Alperovitch A, Berr C, Belmin J, Legrain S, Saint-Jean O, Tavernier B, Dartigues JF, Fourrier-Reglat A (2005) Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Eur J Clin Pharmacol 60(11):813–819PubMedCrossRefGoogle Scholar
- 52.Centre of Medicare and Medicaid Services (CMS) (2006) List of unnecessary Medications Used in Residents of Long-Term Care Facilities http://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R22SOMA.pdf. Accessed 22.03. 2011
- 63.Basger BJ, Chen TF, Moles RJ (2012) Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open 2(5)Google Scholar
- 64.Brown NJ, Griffin MR, Ray WA, Meredith S, Beers MH, Marren J, Robles M, Stergachis A, Wood AJ, Avorn J (1998) A model for improving medication use in home health care patients. J Am Pharm Assoc (Wash) 38(6):696–702Google Scholar
- 65.New South Wales Therapeutic Advisory Group (2007) Indicators for Quality Use of Medicines in Australian Hospitals. http://www.ciap.health.nsw.gov.au/nswtag/documents/publications/indicators/manual.pdf. Accessed 01.05. 2011
- 72.Drenth-van Maanen AC, van Marum RJ, Knol W, van der Linden CM, Jansen PA (2009) Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging 26(8):687–701PubMedCrossRefGoogle Scholar
- 74.Ruggiero C, Dell'Aquila G, Gasperini B, Onder G, Lattanzio F, Volpato S, Corsonello A, Maraldi C, Bernabei R, Cherubini A (2010) Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging 27(9):747–758PubMedCrossRefGoogle Scholar